TransMedics Group's market cap is currently $3.88B. The company's EPS TTM is $0.92; its P/E ratio is 58.88; TransMedics Group is scheduled to report earnings on July 30, 2025, and the estimated EPS forecast is $0.36. See an overview of income statement, balance sheet, and cash flow financials.
